Yet services for the two diseases are insufficiently integrated. 항레트로바이러스 치료를 받던 사람이 결핵으로 사망하면 어떤 혜택을 받을 수 있을까요? These are just some of the practical, sometimes lifeanddeath questions that have major policy implications.